Easterly Investment Partners’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-45,448
Closed -$14.9M 174
2025
Q4
$14.9M Sell
45,448
-6,157
-12% -$1.95M 0.91% 24
2025
Q3
$14.6M Buy
51,605
+94
+0.2% +$27.3K 0.99% 23
2025
Q2
$14.4M Sell
51,511
-3,205
-6% -$908K 1.03% 23
2025
Q1
$17M Buy
54,716
+2,202
+4% +$650K 1.42% 14
2024
Q4
$13.7M Buy
52,514
+566
+1% +$168K 1.07% 22
2024
Q3
$16.7M Sell
51,948
-3,665
-7% -$1.2M 1.34% 12
2024
Q2
$17.4M Sell
55,613
-1,104
-2% -$324K 1.53% 9
2024
Q1
$16.1M Sell
56,717
-216
-0.4% -$63.2K 1.23% 18
2023
Q4
$16.4M Buy
56,933
+17,490
+44% +$4.77M 1.75% 11
2023
Q3
$10.6M Buy
39,443
+2,386
+6% +$595K 1.17% 29
2023
Q2
$8.23M Buy
37,057
+30,850
+497% +$7.16M 0.73% 61
2023
Q1
$1.5M Sell
6,207
-460
-7% -$113K 0.13% 122
2022
Q4
$1.75M Sell
6,667
-7,222
-52% -$1.94M 0.15% 119
2022
Q3
$3.13M Sell
13,889
-1,954
-12% -$474K 0.3% 82
2022
Q2
$3.85M Sell
15,843
-4,533
-22% -$1.11M 0.34% 80
2022
Q1
$4.93M Buy
20,376
+8,008
+65% +$1.84M 0.37% 75
2021
Q4
$2.78M Buy
12,368
+2,249
+22% +$475K 0.2% 96
2021
Q3
$2.15M Buy
+10,119
New +$2.33M 0.15% 108

Other funds holding AMGN

Easterly Investment Partners's AMGN Position: Q1 2026 in Review

Easterly Investment Partners sold out of Amgen (AMGN) in Q1 2026, closing a stake of 45,448 shares — an estimated $14.9M sold.

Easterly Investment Partners first reported a position in AMGN in Q3 2021 and held it in 18 quarters. The position peaked at $17.4M in Q2 2024. 3,129 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Easterly Investment Partners reported no remaining Amgen position as of Q1 2026 after selling out during the quarter.
  • Easterly Investment Partners sold 45,448 Amgen shares in Q1 2026, an estimated $14.9M.
  • Easterly Investment Partners first reported a position in Amgen in Q3 2021 and held it in 18 quarters.
  • Easterly Investment Partners's Amgen position peaked at $17.4M in Q2 2024.
  • 3,129 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Easterly Investment Partners's 13F filing for Q1 2026, filed 11 May 2026.